Yang Mengge, Sheng Qiqi, Ge Shenghui, Song Xinxin, Dong Jianjun, Guo Congcong, Liao Lin
Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji-nan, China.
Cheeloo College of Medicine, Shandong University, Department of Endocrinology and Metabology, Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Ji-nan, China.
Front Pediatr. 2023 Jan 26;11:1077120. doi: 10.3389/fped.2023.1077120. eCollection 2023.
The genetic and clinical characteristics of patients with distal renal tubular acidosis (dRTA) caused by mutations have not been systematically recorded before. Here, we summarized the mutations and clinical characteristics associated with dRTA.
Database was searched, and the mutations and clinical manifestations of patients were summarized from the relevant articles.
Fifty-three eligible articles involving 169 patients were included and 41 mutations were identified totally. Fifteen mutations involving 100 patients were autosomal dominant inheritance, 21 mutations involving 61 patients were autosomal recessive inheritance. Nephrocalcinosis or kidney stones were found in 72.27%, impairment in renal function in 14.29%, developmental disorders in 61.16%, hematological abnormalities in 33.88%, and muscle weakness in 13.45% of patients. The age of onset was younger ( < 0.01), urine pH was higher ( < 0.01), and serum potassium was lower ( < 0.001) in recessive patients than patients with dominant mutations. Autosomal recessive inheritance was more often found in Asian patients ( < 0.05).
The children present with metabolic acidosis with high urinary pH, accompanying hypokalemia, hyperchloremia, nephrocalcinosis, growth retardation and hematological abnormalities should be suspected as dRTA and suggested a genetic testing. The patients with recessive dRTA are generally more severely affected than that with dominant mutations. Autosomal recessive inheritance was more often found in Asian patients, and more attentions should be paid to the Asian patients.
此前,由突变引起的远端肾小管酸中毒(dRTA)患者的遗传和临床特征尚未得到系统记录。在此,我们总结了与dRTA相关的突变和临床特征。
检索数据库,并从相关文章中总结患者的突变情况和临床表现。
纳入了53篇涉及169例患者的合格文章,共鉴定出41种突变。涉及100例患者的15种突变呈常染色体显性遗传,涉及61例患者的21种突变呈常染色体隐性遗传。72.27%的患者出现肾钙质沉着症或肾结石,14.29%的患者出现肾功能损害,61.16%的患者出现发育障碍,33.88%的患者出现血液学异常,13.45%的患者出现肌无力。隐性遗传患者的发病年龄更小(P<0.01),尿pH值更高(P<0.01),血清钾更低(P<0.001)。亚洲患者中常染色体隐性遗传更为常见(P<0.05)。
对于出现代谢性酸中毒、高尿pH值、伴有低钾血症、高氯血症、肾钙质沉着症、生长发育迟缓及血液学异常的儿童,应怀疑为dRTA,并建议进行基因检测。隐性dRTA患者通常比显性突变患者受影响更严重。亚洲患者中常染色体隐性遗传更为常见,应更加关注亚洲患者。